| 2026-08-11 | 10-Q | 10.2 | Amendment No.4 to Inhibikase Therapeutics, Inc. 2020 Equity Incentive Plan |
|---|
| 2026-08-11 | 10-Q | 10.1 | Non-Employee Director Compensation Policy |
|---|
| 2026-06-29 | 8-K | 10.1 | Amendment No. 4 to Inhibikase Therapeutics, Inc. 2020 Equity Incentive Plan. |
|---|
| 2025-08-14 | 10-Q | 10.1 | Amendment No. 3 to the Inhibikase Therapeutics, Inc. 2020 Equity Incentive Plan |
|---|
| 2025-03-27 | 10-K | 10.30 | Form of Non-Qualified Stock Option Agreement (Non-Plan Inducement Grant) |
|---|
| 2025-03-27 | 10-K | 10.29 | Employment Agreement, by and between Inhibikase Therapeutics, Inc. and Christopher Cabell, dated February 21, 2025 |
|---|
| 2025-03-27 | 10-K | 10.28 | Employment Agreement, by and between Inhibikase Therapeutics, Inc. and Mark Iwicki, dated February 14, 2025 |
|---|
| 2025-03-27 | 10-K | 10.27 | Consulting Agreement, by and between Inhibikase Therapeutics, Inc. and Milton H. Werner, dated February 13, 2025 |
|---|
| 2024-10-10 | 8-K | 10.5 | Settlement Agreement, dated as of September 30, 2024 |
|---|
| 2024-10-10 | 8-K | 10.4 | Form of Director Offer Letter |
|---|
| 2024-10-10 | 8-K | 10.3 | Form of Support Agreement |
|---|
| 2024-10-10 | 8-K | 10.2 | Form of Registration Rights Agreement |
|---|
| 2024-10-10 | 8-K | 10.1 | Securities Purchase Agreement, dated as of October 9, 2024 |
|---|
| 2024-05-20 | 8-K | 10.3 | Inducement Letter, dated as of May 20, 2024 |
|---|
| 2024-05-20 | 8-K | 10.2 | Placement Agency Agreement, dated as of May 20, 2024 |
|---|
| 2024-05-20 | 8-K | 10.1 | Securities Purchase Agreement, dated as of May 20, 2024 |
|---|
| 2024-02-01 | 8-K | 10.1 | At The Market Offering Agreement, dated February 1, 2024, by and between Inhibikase Therapeutics, Inc. and H.C. Wainwright & Co., LLC. |
|---|
| 2023-01-26 | 8-K | 10.3 | Registration Rights Agreement, dated as of January 25, 2023 (PIPE) |
|---|
| 2023-01-26 | 8-K | 10.2 | Securities Purchase Agreement, dated as of January 25, 2023 (PIPE) |
|---|
| 2023-01-26 | 8-K | 10.1 | Securities Purchase Agreement, dated as of January 25, 2023 (Registered Direct) |
|---|
| 2022-09-01 | 8-K | 10.1 | Form of Director Offer Letter |
|---|
| 2022-05-17 | 8-K | 10.1 | Equity Distribution Agreement, dated May 16, 2022, by and between Inhibikase Therapeutics, Inc. and Piper Sandler & Co. |
|---|
| 2022-03-08 | 8-K | 10.3 | Form of Stock Option Grant Notice and Award Agreement. |
|---|
| 2022-03-08 | 8-K | 10.2 | Amendment dated March 3, 2021 to the Employment Agreement, by and between Inhibikase Therapeutics, Inc. and Joseph Frattaroli, dated October 24, 2018. |
|---|
| 2022-03-08 | 8-K | 10.1 | Amendment dated March 3, 2021 to the Employment Agreement, by and between Inhibikase Therapeutics, Inc. and Milton H. Werner, Ph.D., dated December 28, 2020. |
|---|